Global Veterinary Drugs Market Set to Reach $48B by 2033
The global and U.S. veterinary drugs market is expected to experience significant growth over the next few years, according to research by CMI. The market size is projected to increase from USD 24,905.8 Mn in 2026 to USD 48,197.5 Mn by 2033, registering a compound annual growth rate (CAGR) of 9.9%.
This growth can be attributed to various factors, including the increasing demand for veterinary care, advancements in medical technology, and the growing pet population. The report also highlights key market trends, emerging technologies, and industry developments that will shape the market through 2033.
The study provides a comprehensive assessment of the global and U.S. veterinary drugs market, covering factors such as market drivers, growth restraints, opportunities, challenges, and future growth prospects. It also evaluates the competitive landscape, with profiles of leading companies such as Zoetis Inc., Boehringer Ingelheim International GmbH, and Merck & Co. Inc.